Dr John Moore

Back to

Dr John Moore

Conjoint Professor

MB.BS, MD, FRACP, FRCPA

Medicine & Health

School of Clinical Medicine

Phone

+61 2 93555656

E-mail

jmoore@stvincents.com.au

Location

Kinghorn Cancer Centre 370 Victoria Rd Darlinghurst NSW, 2010 Australia

Book Chapters | 2021

Penglase R; Sandler RD; Moore J; Snowden JA, 2021, 'Hematopoietic Stem Cell Transplantation for Rheumatoid Arthritis', in Hematopoietic Stem Cell Transplantation and Cellular Therapies for Autoimmune Diseases, pp. 547 - 556,
Journal articles | 2024

Abadir E; Othman J; Kwan J; Gottlieb DJ; Kennedy GA; Bajel A; Doocey R; Perera T; Watson AM; Bardy PG; Greenwood M; Curtis DJ; Tran S; Moore J; Hamad N, 2024, 'Peripheral Blood Haploidentical Allogeneic Stem Cell Transplantation in Older Adults with Acute Myeloid Leukemia and Myelodysplastic Syndromes Demonstrates Long Term Survival, Results from Australia and New Zealand Transplant and Cellular Therapies', Transplantation and Cellular Therapy, 30, pp. 334.e1 - 334.e7,

Journal articles | 2024

Gregory K; Hansen D; Penglase R; Apostolopoulos D; Ngian GS; Stevens W; Morrisroe K; Ferdowsi N; Ross L; Walker J; Cooley H; Youssef P; Tymms K; Host L; Proudman S; Moore J; Nikpour M; Sahhar J, 2024, 'Outcomes of Patients With Diffuse Systemic Sclerosis Eligible for Autologous Stem Cell Transplantation Treated With Conventional Therapy', Arthritis and Rheumatology, 76, pp. 1294 - 1302,

Journal articles | 2024

Penglase R; Girgis L; Englert H; Ma D; Moore J, 2024, 'Australian rheumatologists' perception of autologous haemopoietic stem cell transplantation for the treatment of systemic sclerosis: a cross-sectional survey', Internal Medicine Journal, 54, pp. 1478 - 1482,

Journal articles | 2023

Blennerhassett R; Othman J; Biscoe A; Kliman D; Mills G; Blyth E; Micklethwaite K; Kwan J; Bilmon I; Bhattacharyya A; Panicker S; Fay K; Milliken S; Ma D; Hamad N; Stevenson W; Arthur C; Moore J; Greenwood M; Gottlieb D; Kerridge I, 2023, 'Long-term outcomes of corticosteroid graft versus host disease prophylaxis in peripheral blood allogeneic haemopoietic stem cell transplant: a comparative cohort analysis', Internal Medicine Journal,

Journal articles | 2023

Chadwick V; Kim M; Mills G; Tang C; Anazodo A; Dear R; Rodgers R; Lavee O; Milliken S; McCaughan G; Moore J; Withers B; Hamad N, 2023, 'Rates of Menstrual History-Taking and Counseling With Anticancer Treatments Are Low: People Who Menstruate Deserve Gender-Specific Cancer Care', JNCCN Journal of the National Comprehensive Cancer Network, 21, pp. 366 - 372,

Journal articles | 2023

Fleming S; Reynolds J; Bajel A; Venn N; Kwan J; Moore J; Yeung D; Pati N; Leahy M; Kollipara S; Verner E; Berkahn L; Sutton R; Wei A; Greenwood M, 2023, 'P365: SEQUENTIAL BLINATUMOMAB WITH REDUCED INTENSITY CHEMOTHERAPY FOR OLDER ADULTS WITH NEWLY DIAGNOSED PH- B-PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA – FINAL RESULTS OF THE ALLG ALL08 STUDY', HemaSphere, 7, pp. e811479d - e811479d,

Journal articles | 2023

Massey J; Artuz C; Dyer Z; Jackson K; Khoo M; Visweswaran M; Withers B; Moore J; Ma D; Sutton I, 2023, 'Diversification and expansion of the EBV-reactive cytotoxic T lymphocyte repertoire following autologous haematopoietic stem cell transplant for multiple sclerosis', Clinical Immunology, 254,

Journal articles | 2023

Massey J; Visweswaran M; Khoo M; Hendrawan K; Sutton I; Withers B; Ma D; Moore J, 2023, 'Detailed immunophenotyping of the hematopoietic graft from patients with multiple sclerosis undergoing autologous hematopoietic stem cell transplant', Cytotherapy, 25, pp. 1271 - 1276,

Journal articles | 2023

McErlean G; Tapp C; Brice L; Gilroy N; Kabir M; Greenwood M; Larsen SR; Moore J; Gottlieb D; Hertzberg M; Brown L; Hogg M; Huang G; Ward C; Kerridge I, 2023, 'Predictors of post traumatic growth in allogeneic hematopoietic stem cell transplantation survivors: a cross-sectional survey', BMC Psychology, 11,

Journal articles | 2023

McErlean G; Tapp C; Brice L; Pradhan A; Gilroy N; Kabir M; Greenwood M; Larsen SR; Moore J; Gottlieb D; Hertzberg M; Brown L; Hogg M; Huang G; Ward C; Kerridge I, 2023, 'Decisional Regret in Long-Term Australian Allogeneic Hematopoietic Stem Cell Transplantation Survivors: A Cross-Sectional Survey', Clinical Nursing Research, 32, pp. 1134 - 1144,

Journal articles | 2023

Moore J; Hamad N; Gottlieb DJ; Bajel A; Ritchie DS; Yeung DT; Greenwood M; Purtill D; Tran S; Solterbeck A; Aarons D; Kwan J, 2023, 'Early cessation of calcineurin inhibitors is feasible post haploidentical blood stem cell transplant-the ANZHIT-1 study.', Blood Adv,

Journal articles | 2023

Penglase R; Girgis L; Englert H; Brennan X; Jabbour A; Kotlyar E; Ma D; Moore J, 2023, 'Cardiotoxicity in autologous haematopoietic stem cell transplantation for systemic sclerosis', Journal of Scleroderma and Related Disorders, 8, pp. 87 - 100,

Journal articles | 2023

Rees MJ; Dickinson M; Paterson J; Ng TF; Grigg A; Moore J; Blombery P; Seymour JF, 2023, 'Targeting the BRAF pathway in haematological diseases', Internal Medicine Journal, 53, pp. 845 - 849,

Journal articles | 2022

Achini-Gutzwiller FR; Snowden JA; Corbacioglu S; Greco R; Alexander T; Badoglio M; Labopin M; Abinun M; Apte S; Arnold R; Domenech A; Brierley C; Burman J; Castilla-Llorente C; Cooper N; Daghia G; Daikeler T; del Papa N; de Vries-Bouwstra J; Farge D; Finke J; Hagglund H; Hawkey C; Henes J; Hiepe F; Jessop H; Kiely D; Kazmi M; Kirgizov K; Kramer E; Mancardi G; Marjanovic Z; Martin R; Martin T; Ma D; Moore J; Miller P; Muraro P; Oliveira MC; Polushin A; Onida F; Simoes B; Puyade M; Resnick I; Ricart E; Rovira M; Saccardi R; Saif M; Sakellari I; Sharrack B; Snarski E; Scherer HU; Sossa C; Withers B; Wulffraat N; Zaccara E; Amrolia P; Ansari M; Balduzzi A; Dalassier A; Dalle JH; Diaz CH; Feuchtinger T; Locatelli F; Lucchini G; Galimard JE; Vincent MG; Handgretinger R; Kleinschmidt K; Lawitschka A; Martinez AP; Peters C; Rocha V; Ruggeri A; Sedlacek P; Svec P; Toporski J; Yesilipek A, 2022, 'Haematopoietic stem cell transplantation for severe autoimmune diseases in children: A review of current literature, registry activity and future directions on behalf of the autoimmune diseases and paediatric diseases working parties of the European Society for Blood and Marrow Transplantation', British Journal of Haematology, 198, pp. 24 - 45,

Journal articles | 2022

Brennan X; Withers B; Jabbour A; Milliken S; Kotlyar E; Fay K; Ma D; Muthiah K; Hamad N; Dodds A; Bart N; Keogh A; Hayward C; Macdonald P; Moore J, 2022, 'Efficacy of bortezomib, cyclophosphamide and dexamethasone in cardiac AL amyloidosis', Internal Medicine Journal, 52, pp. 1826 - 1830,

Journal articles | 2022

Hendrawan K; Khoo MLM; Visweswaran M; Massey JC; Withers B; Sutton I; Ma DDF; Moore JJ, 2022, 'Long-Term Suppression of Circulating Proinflammatory Cytokines in Multiple Sclerosis Patients Following Autologous Haematopoietic Stem Cell Transplantation', Frontiers in Immunology, 12,

Journal articles | 2022

Hsu H; Seah V; Marriott D; Moore J, 2022, 'Enterococcus cecorum infective endocarditis in a patient with chronic myeloid leukaemia and cirrhosis', Pathology, 54, pp. 495 - 497,

Journal articles | 2022

Kliman D; Tran S; Kennedy G; Curley C; McLean A; Gottlieb D; Kwan J; Ritchie D; Chee L; Spencer A; Purtill D; Bardy P; Larsen S; Chien N; Perera T; Greenwood M; Hamad N; Moore J, 2022, 'The improvement in overall survival from unrelated donor transplantation in Australia and New Zealand is driven by a reduction in non-relapse mortality: A study from the ABMTRR', Bone Marrow Transplantation, 57, pp. 982 - 989,

Journal articles | 2022

Massey J; Jackson K; Singh M; Hughes B; Withers B; Ford C; Khoo M; Hendrawan K; Zaunders J; Charmeteau-De Muylder B; Cheynier R; Luciani F; Ma D; Moore J; Sutton I, 2022, 'Haematopoietic Stem Cell Transplantation Results in Extensive Remodelling of the Clonal T Cell Repertoire in Multiple Sclerosis', Frontiers in Immunology, 13,

Journal articles | 2022

McCaughan GJ; Gandolfi S; Moore JJ; Richardson PG, 2022, 'Lenalidomide, bortezomib and dexamethasone induction therapy for the treatment of newly diagnosed multiple myeloma: a practical review', British Journal of Haematology, 199, pp. 190 - 204,

Journal articles | 2022

McErlean G; Brice L; Gilroy N; Kabir M; Greenwood M; Larsen SR; Moore J; Gottlieb D; Hertzberg M; Brown L; Hogg M; Huang G; Ward C; Kerridge I, 2022, 'Long-term treatment burden following allogeneic blood and marrow transplantation in NSW, Australia: a cross-sectional survey', Journal of Cancer Survivorship, 16, pp. 432 - 444,

Journal articles | 2022

Nivison-Smith I; Bajel A; Dodds AJ; Gottlieb D; Hamad N; Kennedy G; Kerridge I; Ma DDF; Milliken S; Moore J; Purtill D; Szer J, 2022, 'Effect of donor age on adult unrelated donor haemopoietic cell transplant outcome: the Australian experience', Internal Medicine Journal, 52, pp. 57 - 62,

Journal articles | 2022

Penglase R; Englert H; Tymms K; Carr A; Ma D; Milliken S; Moore J, 2022, 'Successful lymphoablative autologous haematopoietic stem cell transplantation in three cases of severe autoimmune disease despite reduced dose cyclophosphamide conditioning—do we need 200 mg/kg cyclophosphamide?', Bone Marrow Transplantation, 57, pp. 1207 - 1209,

Journal articles | 2022

Visweswaran M; Hendrawan K; Massey JC; Khoo ML; Ford CD; Zaunders JJ; Withers B; Sutton IJ; Ma DDF; Moore JJ, 2022, 'Sustained immunotolerance in multiple sclerosis after stem cell transplant', Annals of Clinical and Translational Neurology, 9, pp. 206 - 220,

Journal articles | 2022

Withers B; McCaughan G; Hayward C; Kotlyar E; Jabbour A; Rainer S; De Angelis E; Horvath N; Milliken S; Dogan A; MacDonald P; Moore J, 2022, 'Clinical characteristics and prognosis of cardiac amyloidosis defined by mass spectrometry-based proteomics in an Australian cohort', Internal Medicine Journal, 52, pp. 69 - 78,

Journal articles | 2021

Abadir E; Othman J; Kwan J; Gottlieb DJ; Kennedy GA; Bajel A; Doocey R; Perera T; Watson A-M; Bardy PG; Greenwood M; Curtis DJ; Tran S; Moore J; Hamad N, 2021, 'Peripheral Blood Haploidentical Allogeneic Stem Cell Transplantation in Older Adults with AML/MDS Demonstrates Excellent Long Term Overall Survival, Results from the Australasian Bone Marrow Transplant Recipient Registry', Blood, 138, pp. 2929 - 2929,

Journal articles | 2021

Blennerhassett R; Moses JH; Coulits N; Horne A; Simpson J; Marshall J; Weston L; Moore J, 2021, 'Recurrent secondary graft failure likely due to a DRB4 donor-specific antibody in a patient with aplastic anemia and DRB4 null allele', Bone Marrow Transplantation, 56, pp. 2603 - 2605,

Journal articles | 2021

Brice L; Gilroy N; Dyer G; Kabir M; Greenwood M; Larsen S; Moore J; Gottlieb D; Hertzberg M; Brown L; Hogg M; Huang G; Ward C; Kerridge I, 2021, 'Predictors of quality of life in allogeneic hematopoietic stem cell transplantation survivors', Journal of Psychosocial Oncology, 39, pp. 534 - 552,

Journal articles | 2021

Cashman H; Mayson E; Kliman D; Kesby J; Bell J; Vachalec S; Withers B; Lavee O; Milliken S; Moore J; Hamad N, 2021, 'Integrated electronic health record facilitates a safer and more efficient rural outreach haematology service', Internal Medicine Journal, 51, pp. 1869 - 1875,

Journal articles | 2021

Chadwick VL; Mills G; Di Ciaccio PR; Tang C; Dear R; Moore J; Milliken S; Withers B; Lavee O; McCaughan GJ; Perram J; Hamad N, 2021, 'A Minority of Women of Child Bearing Potential Are Tested for Pregnancy before Chemoimmunotherapy: An Australian Cancer Centre Experience', BLOOD, 138,

Journal articles | 2021

Chatterton S; Withers B; Sutton IJ; Milliken ST; Ma DDF; Moore JJ; Massey JC, 2021, 'Pregnancy post autologous stem cell transplant with BEAM conditioning for multiple sclerosis', Multiple Sclerosis Journal, 27, pp. 2112 - 2115,

Journal articles | 2021

Fleming S; Reynolds J; Bajel A; Venn N; Kwan J; Moore J; Yeung DT; Pati N; Leahy MF; Nkyekyer J; Verner E; Berkahn L; Sutton R; Wei AH; Greenwood M, 2021, 'Sequential Blinatumomab with Reduced Intensity Chemotherapy in the Treatment of Older Adults with Newly Diagnosed Ph Negative B-Precursor Acute Lymphoblastic Leukemia - Interim Analysis of the Australasian Leukemia and Lymphoma Group ALL08 Study', BLOOD, 138,

Journal articles | 2021

Kennedy GA; Tey SK; Buizen L; Varelias A; Gartlan KH; Curley C; Olver SD; Chang K; Butler JP; Misra A; Subramoniapillai E; Morton AJ; Durrant S; Henden AS; Moore J; Ritchie D; Gottlieb D; Cooney J; Paul SK; Hill GR, 2021, 'A phase 3 double-blind study of the addition of tocilizumab vs placebo to cyclosporin/methotrexate GVHD prophylaxis', Blood, 137, pp. 1970 - 1979,

Journal articles | 2021

McCaughan G; Ma D; Moore J, 2021, 'Two cases of successful autologous stem cell transplantation in patients with multiple myeloma and concurrent chronic myeloid leukaemia', Bone Marrow Transplantation, 56, pp. 514 - 516,

Journal articles | 2021

McCaughan GJ; Verma A; Ling S; Lavee O; Moore JJ; Bryant A, 2021, 'Weekly cyclophosphamide, subcutaneous bortezomib and dexamethathasone (CyBorD) for initial treatment of transplant-eligible patients with multiple myeloma: experience of two transplant centres', Bone Marrow Transplantation, 56, pp. 738 - 740,

Journal articles | 2021

Mills G; Moore J; Cliff E; Fong CY; Mangalasseril S; Tiley C; Gilbertson M; Ku M; Bazargan A; Bryson M; Menzies Wojtowicz M; Sungala NP; Cunningham I; Tang C; Hamad N, 2021, 'Promising Real World Survival Data in Adult-Onset Langerhans Cell Histiocytosis: An Australasian Lymphoma Alliance 20 Year Retrospective Study', Blood, 138, pp. 2570 - 2570,

Journal articles | 2021

Murray DD; Zaunders J; Milliken ST; Mee Ling Munier C; Ford C; Orla Morrissey C; Visweswaran M; Avery S; Sasadeusz J; Kwan J; Desai S; Law M; Koelsch KK; Lewin SR; Moore J; Kelleher AD; Polizzotto MN; Munier ML; Law M, 2021, 'Altered Immune Reconstitution in Allogeneic Stem Cell Transplant Recipients with Human Immunodeficiency Virus (HIV)', Clinical Infectious Diseases, 72, pp. 1141 - 1146,

Journal articles | 2021

Perram J; Mayson E; Tang C; Tran S; Aarons D; Dodds AJ; Fay K; Hamad N; Ma D; Milliken S; Withers B; Greenwood M; Stevenson WS; Arthur CK; Kerridge IH; Moore J, 2021, 'Outcomes for Allogeneic Stem Cell Transplantation in Secondary AML Are Inferior to De Novo AML and Are Independent of the Disease Risk Index', BLOOD, 138,

Journal articles | 2021

Snowden JA; Styczyński J; Snarski E; Greco R; Badoglio M; Labopin M; Abinun M; Apte S; Arnold R; Boglione C; Brierley C; Burman J; Castilla-Llorente C; Cooper N; Daghia G; Daikeler T; del Papa N; de Vries-Bouwstra J; Farge D; Finke J; Hagglund H; Hawkey C; Henes J; Hiepe F; Jessop H; Kiely D; Kazmi M; Kirgizov K; Kramer E; Mancardi G; Marjanovic Z; Martin R; Martin T; Ma D; Moore J; Miller P; Muraro P; Oliveira MC; Polushin A; Onida F; Simoes B; Puyade M; Resnick I; Ricart E; Rovira M; Saccardi R; Saif M; Sakellari I; Sharrack B; Scherer HU; Sossa C; Withers B; Wulffraat N; Zaccara E, 2021, 'Hematopoietic stem cell transplantation in autoimmune diseases: update from the EBMT Autoimmune Diseases Working Party with special reference to Poland', Acta Haematologica Polonica, 52, pp. 217 - 224,

Journal articles | 2020

Brice L; McErlean G; Donovan C; Tapp C; Gilroy N; Kabir M; Greenwood M; Larsen SR; Moore J; Gottlieb D; Hertzberg M; Brown L; Hogg M; Huang G; Tan J; Ward C; Kerridge I, 2020, 'Fear of cancer recurrence following allogeneic haematopoietic stem cell transplantation (HSCT) for haematological malignancy: A cross-sectional study', European Journal of Oncology Nursing, 49,

Journal articles | 2020

Cashman H; Mayson E; Kliman D; Vachalec S; Bell J; Milliken S; Moore J; Lavee O; Withers B; Hamad N, 2020, 'A Shared Electronic Health Record in a Rural Setting Maintains Hematological Cancer Services Remotely during the COVID-19 Pandemic', Blood, 136, pp. 5 - 5,

Journal articles | 2020

Hendrawan K; Visweswaran M; Ma DDF; Moore JJ, 2020, 'Tolerance regeneration by T regulatory cells in autologous haematopoietic stem cell transplantation for autoimmune diseases', Bone Marrow Transplantation, 55, pp. 857 - 866,

Journal articles | 2020

McCaughan GJ; Verma A; Ling S; Lavee O; Moore J; Bryant A, 2020, 'Weekly Cyclophosphamide, Subcutaneous Bortezomib and Dexamethathasone (CyBorD) for Initial Treatment of Transplant Eligible Patients with Multiple Myeloma: Experience of Two Transplant Centres', Blood, 136, pp. 42 - 43,

Journal articles | 2020

Moore J; Kwan J; Gottlieb D; Bajel A; Ritchie D; Yeung DT; Greenwood M; Purtill D; Tran S; Aarons D; Hamad N, 2020, 'A Prospective Haploidentical Peripheral Blood Stem Cell Transplant Study Using a Pre-Defined Conditioning Regimen Intensity Based on Age and the Hematopoietic Cell Transplantation Comorbidity Index- Anzhit 1: Encouraging Preliminary Survival Outcomes at One Year Follow up', Blood, 136, pp. 51 - 52,

Journal articles | 2020

Othman J; Greenwood M; Moore J; Larsen S; Watson AM; Arthur C; Bhattacharyya A; Bilmon I; Blyth E; Bryant A; Bryant C; Dunlop L; Fay K; Gibson J; Hamad N; Kerridge I; Kwan J; Ma D; Micklethwaite K; Milliken S; Panicker S; Stevenson W; Withers B; Wilcox L; Tran S; Gottlieb DJ, 2020, 'Unrelated Donor Transplant Recipients Given Thymoglobuline Have Superior GRFS When Compared to Matched Related Donor Recipients Undergoing Transplantation without ATG', Biology of Blood and Marrow Transplantation, 26, pp. 1868 - 1875,

Journal articles | 2020

Sharrack B; Saccardi R; Alexander T; Badoglio M; Burman J; Farge D; Greco R; Jessop H; Kazmi M; Kirgizov K; Labopin M; Mancardi G; Martin R; Moore J; Muraro PA; Rovira M; Sormani MP; Snowden JA; Snowden J; McGrath E; Bambi F; Sanchez-Guijo F; Worel N; Badolglio M; Abinun M; Arnold R; Brierley C; Castilla-Llorente C; Cooper N; Daikeler T; del Papa N; Finke J; Reax R; Hagglund H; Henes J; Hiepe F; Kiely D; Mancardi G; Marjanovic Z; Martin R; Martin T; Ma D; Moore J; Miller P; Muraro P; Oliveira MC; Polushin A; Onida F; Simoes B; Puyade M; Resnick I; Saif M; Sakellari I; Snarski E; Scherer HU; Sossa C; de Vries-Bouwstra J; Wulffraat N; Zaccara E, 2020, 'Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases: updated guidelines and recommendations from the EBMT Autoimmune Diseases Working Party (ADWP) and the Joint Accreditation Committee of EBMT and ISCT (JACIE)', Bone Marrow Transplantation, 55, pp. 283 - 306,

Journal articles | 2020

Sharrack B; Saccardi R; Alexander T; Manuela B; Burman J; Farge D; Greco R; Jessop H; Kazmi M; Kirgizov K; Labopin M; Mancardi G; Martin R; Moore J; Muraro P; Rovira M; Sormani MP; Snowden J, 2020, 'Autologous haematopoietic stem cell transplantation in multiple sclerosis and other immune-mediated neurological diseases: guidelines and recommendations of the European Society for Blood and Marrow Transplantation and the Joint Accreditation Committee of the International Society for Cellular Therapy (4540)', Neurology, 94,

Journal articles | 2020

Snowden JA; Saccardi R; Orchard K; Ljungman P; Duarte RF; Labopin M; McGrath E; Brook N; de Elvira CR; Gordon D; Poirel HA; Ayuk F; Beguin Y; Bonifazi F; Gratwohl A; Milpied N; Moore J; Passweg J; Rizzo JD; Spellman SR; Sierra J; Solano C; Sanchez-Guijo F; Worel N; Gusi A; Adams G; Balan T; Baldomero H; Macq G; Marry E; Mesnil F; Oldani E; Pearce R; Perry J; Raus N; Schanz U; Tran S; Wilcox L; Basak GW; Chabannon C; Corbacioglu S; Dolstra H; Kuball J; Mohty M; Lankester A; Montoto S; Nagler A; Styczynski J; Yakoub-Agha I; de Latour RP; Kroeger N; Brand R; de Wreede LC; van Zwet E; Putter H, 2020, 'Benchmarking of survival outcomes following haematopoietic stem cell transplantation: A review of existing processes and the introduction of an international system from the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)', Bone Marrow Transplantation, 55, pp. 681 - 694,

Journal articles | 2020

Snowden JA; Saccardi R; Orchard K; Ljungman P; Duarte RF; Labopin M; McGrath E; Brook N; de Elvira CR; Gordon D; Poirel HA; Ayuk F; Beguin Y; Bonifazi F; Gratwohl A; Milpied N; Moore J; Passweg J; Rizzo JD; Spellman SR; Sierra J; Solano C; Sanchez-Guijo F; Worel N; Gusi A; Adams G; Balan T; Baldomero H; Macq G; Marry E; Mesnil F; Oldani E; Pearce R; Perry J; Raus N; Schanz U; Tran S; Wilcox L; Basak GW; Chabannon C; Corbacioglu S; Dolstra H; Kuball J; Mohty M; Lankester A; Montoto S; Nagler A; Styczynski J; Yakoub-Agha I; de Latour RP; Kroeger N; Brand R; de Wreede LC; van Zwet E; Putter H, 2020, 'Correction: Benchmarking of survival outcomes following haematopoietic stem cell transplantation: A review of existing processes and the introduction of an international system from the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) (Bone Marrow Transplantation, (2020), 55, 4, (681-694), 10.1038/s41409-019-0718-7)', Bone Marrow Transplantation, 55, pp. 838 - 839,

Journal articles | 2020

Walker I; Panzarella T; Couban S; Couture F; Devins G; Elemary M; Gallagher G; Kerr H; Kuruvilla J; Lee SJ; Moore J; Nevill T; Popradi G; Roy J; Schultz KR; Szwajcer D; Toze C; Foley R, 2020, 'Addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis versus standard treatment alone in patients with haematological malignancies undergoing transplantation from unrelated donors: final analysis of a randomised, open-label, multicentre, phase 3 trial', The Lancet Haematology, 7, pp. e100 - e111,

Journal articles | 2019

Abeysinghe P; Morawaka L; Gunasekara S; Suresh S; Jayathilake P; Udara P; Siriwardena P; Milliken S; Moore J; Ma D, 2019, 'Country Report: The Report of Transplant Activity and Outcome During the First 12 Months at the First National Hematopoietic Stem Cell Transplant Center in Sri Lanka.', Blood Cell Ther, 2, pp. 50 - 53,

Journal articles | 2019

Dyer G; Gilroy N; Brice L; Kabir M; Gottlieb D; Huang G; Hogg M; Brown L; Greenwood M; Larsen SR; Moore J; Hertzberg M; Tan J; Ward C; Kerridge I, 2019, 'A survey of infectious diseases and vaccination uptake in long-term hematopoietic stem cell transplant survivors in Australia', Transplant Infectious Disease, 21,

Journal articles | 2019

Ismail A; Sharrack B; Saccardi R; Moore JJ; Snowden JA, 2019, 'Autologous haematopoietic stem cell therapy for multiple sclerosis: A review for supportive care clinicians on behalf of the Autoimmune Diseases Working Party of the European Society for Blood and Marrow Transplantation', Current Opinion in Supportive and Palliative Care, 13, pp. 394 - 401,

Journal articles | 2019

Jessop H; Farge D; Saccardi R; Alexander T; Rovira M; Sharrack B; Greco R; Wulffraat N; Moore J; Kazmi M; Badoglio M; Adams G; Verhoeven B; Murray J; Snowden JA, 2019, 'General information for patients and carers considering haematopoietic stem cell transplantation (HSCT) for severe autoimmune diseases (ADs): A position statement from the EBMT Autoimmune Diseases Working Party (ADWP), the EBMT Nurses Group, the EBMT Patient, Family and Donor Committee and the Joint Accreditation Committee of ISCT and EBMT (JACIE)', Bone Marrow Transplantation, 54, pp. 933 - 942,

Journal articles | 2019

Kennedy GA; Tey S-K; Curley C; Butler JP; Misra A; Subramoniapillai E; Morton J; Durrant S; Hendon AS; Moore J; Ritchie D; Gottlieb D; Cooney J; Buizen L; Paul SK; Hill GR, 2019, 'Results of a Phase III Double-Blind Study of the Addition of Tocilizumab Vs. Placebo to Cyclosporin/Methotrexate Gvhd Prophylaxis after HLA-Matched Allogeneic Stem Cell Transplantation', Blood, 134, pp. 368 - 368,

Journal articles | 2019

McCarthy R-L; McNamee N; Copelin B; Mills G; Wong S; Qiu MR; Earls P; Milliken S; Hamad N; Fay K; Lukeis R; Parker A; Moore J, 2019, 'A case series of langerhans cell histiocytosis with braf testing', Pathology, 51, pp. S92 - S92,

Journal articles | 2019

Moore JJ; Massey JC; Ford CD; Khoo ML; Zaunders JJ; Hendrawan K; Barnett Y; Barnett MH; Kyle KA; Zivadinov R; Ma KC; Milliken ST; Sutton IJ; Ma DDF, 2019, 'Prospective phase II clinical trial of autologous haematopoietic stem cell transplant for treatment refractory multiple sclerosis', Journal of Neurology, Neurosurgery and Psychiatry, 90, pp. 514 - 521,

Journal articles | 2019

Roy J; Panzarella T; Couban S; Couture F; Devins GM; Elemary M; Foley SR; Gallagher G; Kuruvilla J; Lee SJ; Moore J; Nevill TJ; Popradi G; Schultz KR; Szwajcer D; Toze CL; Walker I, 2019, 'Less Chronic Graft-Versus-Host Disease, Immunosuppressive Therapy and Better Survival after Anti-Thymocyte Globulin in Unrelated Donor Stem Cell Transplant Recipients: Longer Follow-up of a Multicentre Cell Therapy Transplant Canada Randomized Trial', Blood, 134, pp. 875 - 875,

Journal articles | 2019

Saccardi R; Badoglio M; Burman J; Helbig G; Kazmi MA; Mancardi G; Mielke S; Moore J; Muraro P; Sanz J; Sharrack B; Smilowski M; Sormani MP; Snowden JA, 2019, 'BEAM Vs Cyclophosphamide-Based Conditioning Regimen in Aggressive Multiple Sclerosis: A Retrospective Analysis of European Blood and Marrow Transplantation Society', Blood, 134, pp. 3313 - 3313,

Journal articles | 2018

Abeysinghe P; Morawaka L; Gunasekara S; Suresh S; Udara PHSP; Siriwardena PPR; Milliken S; Ma DDF; Moore J, 2018, 'Working together: Establishment of the first national hematopoietic stem cell transplantation (HSCT) center in Sri Lanka', Blood Advances, 2, pp. 46 - 49,

Journal articles | 2018

Dyer G; Brice L; Gilroy N; Kabir M; Hertzberg M; Greenwood M; Larsen SR; Moore J; Gottlieb D; Huang G; Hogg M; Brown L; Tan J; Ward C; Kerridge I, 2018, 'Changes to work status and household income of long-term allogeneic blood and marrow transplant survivors in New South Wales, Australia', Bone Marrow Transplantation, 53, pp. 926 - 931,

Journal articles | 2018

Dyer G; Brice L; Schifter M; Gilroy N; Kabir M; Hertzberg M; Greenwood M; Larsen SR; Moore J; Gottlieb D; Huang G; Hogg M; Brown L; Tan J; Ward C; Kerridge I, 2018, 'Oral health and dental morbidity in long-term allogeneic blood and marrow transplant survivors in Australia', Australian Dental Journal, 63, pp. 312 - 319,

Journal articles | 2018

Lim ABM; Curley C; Fong CY; Bilmon I; Beligaswatte A; Purtill D; Getta B; Johnston AM; Armytage T; Collins M; Mason K; Fielding K; Greenwood M; Gibson J; Hertzberg M; Wright M; Lewis I; Moore J; Curtis D; Szer J; Kennedy G; Ritchie D, 2018, 'Acute myeloid leukaemia relapsing after allogeneic haemopoietic stem cell transplantation: prognostic factors and impact of initial therapy of relapse', Internal Medicine Journal, 48, pp. 276 - 285,

Journal articles | 2018

Ma CKK; García-Cadenas I; Fox ML; Ai S; Nivison-Smith I; Milliken ST; Dodds A; Fay K; Ma DDF; Martino R; Sierra J; Moore J, 2018, 'Poor prognosis in patients with steroid refractory acute graft versus host disease treated with etanercept: a multi-centre analysis', Bone Marrow Transplantation, 53, pp. 1478 - 1482,

Journal articles | 2018

Massey JC; Sutton IJ; Ma DDF; Moore JJ, 2018, 'Regenerating immunotolerance in multiple sclerosis with autologous hematopoietic stem cell transplant', Frontiers in Immunology, 9,

Journal articles | 2018

Ting YS; Smith SABC; Brown DA; Dodds AJ; Fay KC; Ma DDF; Milliken S; Moore JJ; Sewell WA, 2018, 'CD200 is a useful diagnostic marker for identifying atypical chronic lymphocytic leukemia by flow cytometry', International Journal of Laboratory Hematology, 40, pp. 533 - 539,

Journal articles | 2017

Bradstock KF; Link E; Iulio JD; Szer J; Marlton P; Wei AH; Enno A; Schwarer A; Lewis ID; D’Rozario J; Coyle L; Cull G; Campbell P; Leahy MF; Hahn U; Cannell P; Tiley C; Lowenthal RM; Moore J; Cartwright K; Cunningham I; Taper J; Grigg A; Roberts AW; Benson W; Hertzberg M; Deveridge S; Rowlings P; Mills AK; Gill D; Bardy P; Campbell L; Seymour JF, 2017, 'Idarubicin dose escalation during consolidation therapy for adult acute myeloid leukemia', Journal of Clinical Oncology, 35, pp. 1678 - 1685,

Journal articles | 2017

Brice L; Gilroy N; Dyer G; Kabir M; Greenwood M; Larsen S; Moore J; Kwan J; Hertzberg M; Brown L; Hogg M; Huang G; Tan J; Ward C; Gottlieb D; Kerridge I, 2017, 'Haematopoietic stem cell transplantation survivorship and quality of life: is it a small world after all?', Supportive Care in Cancer, 25, pp. 421 - 427,

Journal articles | 2017

Smith J; Poon C; Gilroy N; Kabir M; Brice L; Dyer G; Hogg M; Greenwood M; Moore J; Hertzberg M; Brown L; Tan J; Huang G; Kwan J; Larsen S; Ward C; Kerridge I, 2017, 'Nutritional issues and body weight in long-term survivors of allogeneic blood and marrow transplant (BMT) in NSW Australia', Supportive Care in Cancer, 25, pp. 137 - 144,

Journal articles | 2017

Snowden JA; Badoglio M; Labopin M; Giebel S; McGrath E; Marjanovic Z; Burman J; Moore J; Rovira M; Wulffraat NM; Kazmi M; Greco R; Snarski E; Kozak T; Kirgizov K; Alexander T; Bader P; Saccardi R; Farge D, 2017, 'Evolution, trends, outcomes, and economics of hematopoietic stem cell transplantation in severe autoimmune diseases', Blood Advances, 1, pp. 2742 - 2755,

Journal articles | 2016

Dyer G; Gilroy N; Bradford J; Brice L; Kabir M; Greenwood M; Larsen SR; Moore J; Hertzberg M; Kwan J; Brown L; Hogg M; Huang G; Tan J; Ward C; Kerridge I, 2016, 'A survey of fertility and sexual health following allogeneic haematopoietic stem cell transplantation in New South Wales, Australia', British Journal of Haematology, 172, pp. 592 - 601,

Journal articles | 2016

Dyer G; Gilroy N; Brown L; Hogg M; Brice L; Kabir M; Greenwood M; Larsen SR; Moore J; Hertzberg M; Kwan J; Huang G; Tan J; Ward C; Kerridge I, 2016, 'What They Want: Inclusion of Blood and Marrow Transplanation Survivor Preference in the Development of Models of Care for Long-Term Health in Sydney, Australia', Biology of Blood and Marrow Transplantation, 22, pp. 731 - 743,

Journal articles | 2016

Dyer G; Larsen SR; Gilroy N; Brice L; Greenwood M; Hertzberg M; Kabir M; Brown L; Hogg M; Huang G; Moore J; Gottlieb D; Kwan J; Tan J; Ward C; Kerridge I, 2016, 'Adherence to cancer screening guidelines in Australian survivors of allogeneic blood and marrow transplantation (BMT)', Cancer Medicine, 5, pp. 1702 - 1716,

Journal articles | 2016

Gifford G; Gilroy N; Dyer G; Brice L; Kabir M; Greenwood M; Larsen S; Moore J; Gottlieb D; Hertzberg M; Kwan J; Huang G; Tan J; Brown L; Hogg M; Ward C; Kerridge I, 2016, 'The experience of survival following allogeneic haematopoietic stem cell transplantation in New South Wales, Australia', Bone Marrow Transplantation, 51, pp. 1361 - 1368,

Journal articles | 2016

Lindsay J; Kabir M; Gilroy N; Dyer G; Brice L; Moore J; Greenwood M; Hertzberg M; Gottlieb D; Larsen SR; Hogg M; Brown L; Huang G; Tan J; Ward C; Kerridge I; Gilroy N, 2016, 'Epidemiology of complementary and alternative medicine therapy use in allogeneic hematopoietic stem cell transplant survivorship patients in Australia', Cancer Medicine, 5, pp. 3606 - 3614,

Journal articles | 2016

Oliveira MC; Labopin M; Henes J; Moore J; Papa ND; Cras A; Sakellari I; Schroers R; Scherer HU; Cuneo A; Kyrcz-Krzemien S; Daikeler T; Alexander T; Finke J; Badoglio M; Simoes B; Snowden JA; Farge D, 2016, 'Erratum: Does ex vivo CD34+ positive selection influence outcome after autologous hematopoietic stem cell transplantation in systemic sclerosis patients? (Bone Marrow Transplantation (2016) 51 (501-505) DOI: 10.1038/bmt.2015.299)', Bone Marrow Transplantation, 51, pp. 889,

Journal articles | 2016

Oliveira MC; Labopin M; Henes J; Moore J; Papa ND; Cras A; Sakellari I; Schroers R; Scherer HU; Cuneo A; Kyrcz-Krzemien S; Daikeler T; Alexander T; Finke J; Badoglio M; Simões B; Snowden JA; Farge D, 2016, 'Does ex vivo CD34+ positive selection influence outcome after autologous hematopoietic stem cell transplantation in systemic sclerosis patients?', Bone Marrow Transplantation, 51, pp. 501 - 505,

Journal articles | 2016

Rebeiro P; Moore J, 2016, 'The role of autologous haemopoietic stem cell transplantation in the treatment of autoimmune disorders', Internal Medicine Journal, 46, pp. 17 - 28,

Journal articles | 2016

Walker I; Panzarella T; Couban S; Couture F; Devins G; Elemary M; Gallagher G; Kerr H; Kuruvilla J; Lee SJ; Moore J; Nevill T; Popradi G; Roy J; Schultz KR; Szwajcer D; Toze C; Foley R, 2016, 'Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from unrelated donors: A randomised, controlled, open-label, phase 3, multicentre trial', The Lancet Oncology, 17, pp. 164 - 173,

Journal articles | 2015

Alexander T; Bondanza A; Muraro PA; Greco R; Saccardi R; Daikeler T; Kazmi M; Hawkey C; Simoes BP; Leblanc K; Fibbe WE; Moore J; Snarski E; Martin T; Hiepe F; Velardi A; Toubert A; Snowden JA; Farge D, 2015, 'SCT for severe autoimmune diseases: Consensus guidelines of the European Society for Blood and Marrow Transplantation for immune monitoring and biobanking', Bone Marrow Transplantation, 50, pp. 173 - 180,

Journal articles | 2015

Iland HJ; Collins M; Bradstock K; Supple S; Catalano A; Hertzberg M; Browett P; Grigg A; Firkin F; Campbell L; Hugman A; Reynolds J; Di Lulio J; Campbell T; Taylor K; Filshie R; Seldon M; Tape J; Szer J; Moore JJ; Bashford J; Seymour JF, 2015, 'Impact of incorporating arsenic trioxide in remission induction and consolidation therapy for acute promyelocytic leukaemia: final analysis of th Australian Leukaemia and Lymphoma Group (ALLG) APML4 non-randomised phase II trial', Lancet (North American Edition), 9, pp. e357 - e366

Journal articles | 2015

Iland HJ; Collins M; Bradstock K; Supple SG; Catalano A; Hertzberg M; Browett P; Grigg A; Firkin F; Campbell LJ; Hugman A; Reynolds J; Di Iulio J; Tiley C; Taylor K; Filshie R; Seldon M; Taper J; Szer J; Moore J; Bashford J; Seymour JF, 2015, 'Use of arsenic trioxide in remission induction and consolidation therapy for acute promyelocytic leukaemia in the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 study: A non-randomised phase 2 trial', The Lancet Haematology, 2, pp. e357 - e366,

Journal articles | 2015

Kumarasinghe G; Lavee O; Parker A; Nivison-Smith I; Milliken S; Dodds A; Joseph J; Fay K; Ma DD; Malouf M; Plit M; Havryk A; Keogh AM; Hayward CS; Kotlyar E; Jabbour A; Glanville AR; Macdonald PS; Moore JJ, 2015, 'Post-transplant lymphoproliferative disease in heart and lung transplantation: Defining risk and prognostic factors', Journal of Heart and Lung Transplantation, 34, pp. 1406 - 1414,

Journal articles | 2015

Shen S; Xu N; Klamer G; Ko KH; Khoo M; Ma D; Moore J; O'Brien TA; Dolnikov A, 2015, 'Small-molecule inhibitor of glycogen synthase kinase 3β 6-bromoindirubin-3-oxime inhibits hematopoietic regeneration in stem cell recipient mice', Stem Cells and Development, 24, pp. 724 - 736,

Journal articles | 2015

Snarski E; Snowden JA; Oliveira MC; Simoes B; Badoglio M; Carlson K; Burman J; Moore J; Rovira M; Clark RE; Saiz A; Hadj-Khelifa S; Tan J; Crescimanno A; Musso M; Martin T; Farge D, 2015, 'Onset and outcome of pregnancy after autologous haematopoietic SCT (AHSCT) for autoimmune diseases: A retrospective study of the EBMT autoimmune diseases working party (ADWP)', Bone Marrow Transplantation, 50, pp. 216 - 220,

Journal articles | 2015

Walker I; Panzarella T; Couban S; Couture F; Devins G; Elemary M; Gallagher G; Kerr H; Kuruvilla J; Lee SJ; Moore J; Nevill T; Popradi G; Roy J; Schultz KR; Szwajcer D; Toze C; Foley R, 2015, 'Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from unrelated donors: A randomised, controlled, open-label, phase 3, multicentre trial', The Lancet Oncology,

Journal articles | 2014

Bilmon I; Nivison-Smith I; Hertzberg M; Ritchie D; Greenwood M; Spencer A; Kennedy G; Bryant A; Moore J, 2014, 'Outcomes following second allogeneic haematopoietic transplants using fludarabine–melphalan conditioning', Bone Marrow Transplantation, 49, pp. 852 - 853,

Journal articles | 2014

Bryant A; Nivison-Smith I; Pillai ES; Kennedy G; Kalff A; Ritchie D; George B; Hertzberg M; Patil S; Spencer A; Fay K; Cannell P; Berkahn L; Doocey R; Spearing R; Moore J, 2014, 'Fludarabine Melphalan reduced-intensity conditioning allotransplanation provides similar disease control in lymphoid and myeloid malignancies: analysis of 344 patients', Bone Marrow Transplantation, 49, pp. 17 - 23,

Journal articles | 2014

Khoo MLM; Carlin SM; Lutherborrow MA; Jayaswal V; Ma DDF; Moore JJ, 2014, 'Gene profiling reveals association between altered Wnt signaling and loss of T-cell potential with age in human hematopoietic stem cells', Aging Cell, 13, pp. 744 - 754,

Journal articles | 2014

Subramaniam K; Yeung D; Grimpen F; Joseph J; Fay K; Buckland M; Talaulikar D; Elijah J; Clarke AC; Pavli P; Moore J, 2014, 'Hepatosplenic T-cell lymphoma, immunosuppressive agents and biologicals: what are the risks?', Internal Medicine Journal, 44, pp. 287 - 290,

Journal articles | 2014

Walker I; Schultz KR; Toze CL; Kerr HM; Moore J; Szwajcer D; Foley SR; Kuruvilla J; Panzarella T; Couture F; Roy J; Couban S; Devins G; Popradi G; Lee SJ; Tay J; Nevill TJ; Elemary M; Gallagher G, 2014, 'Thymoglobulin Decreases the Need for Immunosuppression at 12 Months after Myeloablative and Nonmyeloablative Unrelated Donor Transplantation: CBMTG 0801, a Randomized, Controlled Trial', BLOOD, 124,

Journal articles | 2013

Carlin SM; Ma DD; Moore JJ, 2013, 'T-cell potential of human adult and cord blood hemopoietic stem cells expanded with the use of aryl hydrocarbon receptor antagonists', Cytotherapy, 15, pp. 224 - 230,

Journal articles | 2013

Morrissey CO; Chen SC-A; Sorrell TC; Milliken S; Bardy PG; Bradstock KF; Szer J; Halliday CL; Gilroy NM; Moore J; Schwarer AP; Guy S; Bajel A; Tramontana AR; Spelman T; Slavin MA, 2013, 'Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial', The Lancet Infectious Diseases, 13, pp. 519 - 528,

Journal articles | 2013

Snarski E; Snowden JA; Badoglio M; Carlson K; Burman J; Oliveira MC; Moore J; Tan J; Rovira M; Clark RE; Saiz A; Khelifa SH; Crescimanno A; Laing L; Musso M; Martin T; Farge D, 2013, 'Outcome Of Pregnancy After Autologous Hematopoietic Stem Cell Transplantation (AHSCT) For Autoimmune Diseases (AD): A Retrospective Study Of The EBMT Autoimmune Diseases Working Party (ADWP)', Blood, 122, pp. 4640 - 4640,

Journal articles | 2013

Subramaniam K; Grimpen F; Yeung D; Joseph J; Fay K; Buckland M; Talaulikar D; Elijah J; Clarke AC; Pavli P; Moore J, 2013, 'Immunosuppressive agents and the risk of hepatosplenic gamma delta-T cell lymphoma (HSTCL): Is the risk increased by concomitant use of anti-TNFs?', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 28, pp. 95 - 96,

Journal articles | 2013

Zimmermann H; Choquet S; Dierickx D; Dreyling MH; Moore J; Valentin A; Striefler JK; Riess H; Leblond V; Trappe RU, 2013, 'Early and late posttransplant lymphoproliferative disorder after lung transplantation-34 cases from the European PTLD network', Transplantation, 96,

Journal articles | 2013

Zimmermann H; Choquet S; Moore J; Salles G; Morschhauser F; Lamy T; Jaccard A; Horst HA; Leithäuser M; Dührsen U; Reinke P; Lebranchu Y; Neuhaus R; Lehmkuhl H; Tarella C; Schlattmann P; Riess H; Leblond V; Trappe RU, 2013, 'Baseline differential blood count and prognosis in CD20-positive post-transplant lymphoproliferative disorder in the prospective PTLD-1 trial', Leukemia, 27, pp. 2102 - 2105,

Journal articles | 2012

Carlin S; Khoo ML; Ma DD; Joseph JE, 2012, 'Notch Signalling Inhibits CD4 Expression during Initiation and Differentiation of Human T Cell Lineage', PLoS ONE, 7, pp. e45342,

Journal articles | 2012

Chih S; Mcdonald PS; Mccrohon JA; Ma DD; Moore JJ; Feneley MP; Law MG; Kovacic JC; Graham RM, 2012, 'Granulocyte colony stimulating factor in chronic angina to stimulate neovascularisation: A placebo-controlled crossover trial.', Heart, 98, pp. 282 - 290,

Journal articles | 2012

Iland ; Bradstock K; Supple S; Catalano A; Collins M; Hertzberg M; Browett P; Grigg A; Firkin F; Hugman A; Reynolds J; Di Iulio J; Tiley C; Taylor K; Filshie R; Seldon M; Taper J; Szer J; Moore JJ; Bashford J; Seymour JF, 2012, 'All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4)', Blood, 120, pp. 1570 - 1580,

Journal articles | 2012

Mollee P; Tiley C; Cunningham I; Moore JJ; Prince M, 2012, 'A Phase II study of risk-adapted intravenous Melphalan in patiens with AL Amyloidosis', British Journal of Haematology, 157, pp. 766 - 769,

Journal articles | 2012

Moore J; Englert H; Furlong T; Poon T; Milliken S; Ma D, 2012, 'Auto-HSCT induces sustained responses in severe systemic sclerosis patients failing pulse cyclophosphamide', Bone Marrow Transplantation, 47, pp. 1486 - 1487,

Journal articles | 2012

Moore JJ; Englert H; Furlong TJ, 2012, 'Stem cell transplant induces sustained responses in severe systemic sclerosis patients failing pulse cyclophosphamide', Bone Marrow Transplantation, 47, pp. 1486 - 1487

Journal articles | 2012

Snowden J; Saccardi R; Allez M; Ardizzone S; Arnold RH; Cervera R; Denton CP; Hawkey CJ; Labopin M; Mancardi GL; Martin RP; Moore JJ; Passweg J; Peters C; Rabusin M; Rovira M; Van Laar J; Farge D, 2012, 'Haematopoietic stem cell transplanation (HSCT) in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow transplatation (EBMT)', Bone Marrow Transplantation, 47, pp. 770 - 790

Journal articles | 2012

Snowden JA; Saccardi R; Allez M; Ardizzone S; Arnold R; Cervera R; Denton C; Hawkey C; Labopin M; Mancardi G; Martin R; Moore JJ; Passweg J; Peters C; Rabusin M; Rovira M; Van Laar JM; Farge D, 2012, 'Haematopoietic SCT in severe autoimmune diseases: Updated guidelines of the European group for blood and marrow transplantation', Bone Marrow Transplantation, 47, pp. 770 - 790,

Journal articles | 2011

Bryant AJ; Pillai E; Kennedy G; Kalff A; Ritchie D; George B; Hertzberg M; Patil SS; Spencer A; Fay K; Cannell P; Berkahn L; Doocey R; Spearling R; Nivison-Smith I; Moore J, 2011, 'A Retrospective Analysis of 344 Fludarabine Melphalan RIC Allogeneic Stem Cell Transplants for Myeloid and Lymphoid Malignancies In Australia and New Zealand 1998–2008,', Blood, 118, pp. 4143 - 4143,

Journal articles | 2011

Mollee P; Tiley C; Cunningham I; Moore J; Prince M; Cannell P; Gibbons S; Tate J; Paul S; Gill DS, 2011, 'A Phase II Study of Risk-Adapted Intravenous Melphalan in Patients with AL Amyloidosis,', Blood, 118, pp. 3973 - 3973,

Journal articles | 2011

Nivison-Smith I; Dodds AJ; Dunkley H; Ma DD; Moore JJ; Simpson M; Szer J; Bradstock KF, 2011, 'Increased activity and improved outcome in unrelatred donor haemopoietic stem cell transplants for acute myeloid leukaemia in Australia, 1992-2005', Internal Medicine Journal, 41, pp. 27 - 34,

Journal articles | 2010

Farge D; Labopin M; Tyndall A; Fassas A; Mancardi GL; Van Laar J; Moore JJ; Kozak T; Kotter I; Marmont A; Gratwohl A; Saccardi R, 2010, 'Autologous hematopoietic stem cell transplantation for autoimmune diseases', Haematologica, 95, pp. 284 - 292

Journal articles | 2010

Farge D; Labopin M; Tyndall A; Fassas A; Mancardi GL; Van Laar J; Ouyang J; Kozak T; Moore J; Kötter I; Chesnel V; Marmont A; Gratwohl A; Saccardi R, 2010, 'Autologous hematopoietic stem cell transplantation for autoimmune diseases: An observational study on 12 years' experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases', Haematologica, 95, pp. 284 - 292,

Journal articles | 2010

Sasson SC; Smith S; Seddiki N; Zaunders J; Bryant AJ; Koelsch KK; Weatherall CJ; Munier CM; McGinley C; Yeung J; Mulligan S; Moore JJ; Cooper DA; Milliken ST; Kelleher AD, 2010, 'IL-7 receptor is expressed on adult pre-B-cell acute lymphoblastic leukemia and other B-cell derived neoplasms and correlates with expression of proliferation and survival markers', Cytokine, 50, pp. 58 - 68

Journal articles | 2009

Grimpen F; Yeung D; Joseph J; Fay K; Buckland M; Talaulikar D; Elijah J; Clarke AC; Pavli P; Moore J, 2009, 'Hepatosplenic T cell lymphoma, immunosuppressive agents and biologicals: what are the risks?', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 24, pp. A314 - A314,

Journal articles | 2008

Englert H; Kirkham S; Moore JJ; Poon T; Katelaris C; McGill N; Schrieber L; Manolios N, 2008, 'Autologous stem cell transplantation in diffuse scleroderma: impact on hand structure and function', Internal Medicine Journal, 38, pp. 692 - 696,

Journal articles | 2008

Farge D; Labopin M; Tyndall A; Fassas A; Mancardi GL; Van Laar J; Ouyang J; Kozak T; Moore J; Kötter I; Chesnel V; Marmont A; Gratwohl A; Saccardi R, 2008, 'Autologous Hematopoietic Stem Cell Transplantation (HSCT) for Autoimmune Diseases: 10 Years Experience from the European Group for Blood and Marrow Transplantation (EBMT) Working Party on Autoimmune Diseases', Blood, 112, pp. 164 - 164,

Journal articles | 2008

Farge-Bancel D; Labopin M; Tyndall A; Fassas A; Mancardi G-L; Van Laar J; Moore J; Kötter I; Chesnel V; Marmont A; Gratwohl A; Saccardi R, 2008, 'Autogreffe de cellules souches hématopoïétiques (ASH) au cours de la sclérodermie systémique : 10ans d’expérience du groupe de travail de l’EBMT-EULAR sur les maladies auto-immunes (MAI)', La Revue de Médecine Interne, 29, pp. S300 - S301,

Journal articles | 2008

Kovacic JC; Macdonald PS; Feneley MP; Muller DW; Freund J; Dodds AJ; Milliken ST; Tao H; Itescu S; Moore JJ; Ma DD; Graham RM, 2008, 'Safety and efficacy of consecutive cycles of granulocyte-colony stimulating factor, and an intracoronary CD 133(+) cell infusion in patients with chronic refractory ischemic heart disease: The G-CSF in Angina patients with IHD to stimulate Neovascul', American Heart Journal, 156, pp. 954 - 963

Journal articles | 2008

Kovacic JC; Moore JJ; Herbert AD; Ma DD; Boehm M; Graham RM, 2008, 'Endothelial progenitor cells, angioblasts, and angiogenesis - Old terms reconsidered from a current perspective', Trends in Cardiovascular Medicine, 18, pp. 45 - 51,

Journal articles | 2008

Potter V; Moore J, 2008, 'Randomised trials of graft versus host disease prophylaxis in haemopoietic stem cell transplantation', Reviews on Recent Clinical Trials, 3, pp. 130 - 138,

Journal articles | 2008

Wong LY; Moore J; Hill D; Brenner P; Delprado W; Turner J; Taylor J; Campbell L; Greenfield JR, 2008, 'Custing's syndrome can precipitate diabetes but mask non-Hodgkin's lymphoma', Medical Journal of Australia, 188, pp. 262,

Journal articles | 2008

Wong LY; Moore JJ; Hill D; Brenner PC; Delprado W; Turner J; Taylor J; Campbell L; Greenfield JR, 2008, 'Cushing`s syndrome can precipitate diabetes but mask non-Hodgkin`s lymphoma', Medical Journal of Australia, 188, pp. 262 - 262,

Journal articles | 2007

Brown DA; Moore JJ; Johnen H; Smeets TJ; Bauskin AR; Kuffner T; Weedon H; Milliken ST; Tak PP; Smith MD; Breit SN, 2007, 'Serum macrophage inhibitory cytokine 1 in rheumatoid arthritis - A potential marker of erosive joint destruction', Arthritis Care & Research, 56, pp. 753 - 764,

Journal articles | 2007

Bryant A; Moore JJ; Dodds AJ; Milliken ST; Fay K; Ma DD, 2007, 'Pneumonitis and renal toxicity with sirolimus based GVHD prophylaxis for RIC allogeneic', Haematologica - the Hematology Journal, 92, pp. 516 - 516,

Journal articles | 2007

Kovacic JC; Ma DD; Tao H; Herbert AD; Moore JJ; Graham RM, 2007, 'Phenotypic characterization of CD133+cells suggests a potent hemangioblast population', Circulation Research, 101, pp. E55 - E56,

Journal articles | 2007

Kovacic JC; Macdonald P; Feneley MP; Muller DW; Ma D; Tao H; Freund J; Milliken S; Dodds A; Moore J; Itescu S; Graham RM, 2007, 'Abstract 2669: The Use of Granulocyte-Colony Stimulating Factor in Angina Patients to Stimulate Neovascularization: the GAIN I study', Circulation, 116,

Journal articles | 2007

Kovacic JC; Macdonald PS; Freund J; Rasko J; Allan RM; Fernandes VB; Ma DD; Moore JJ; Graham RM, 2007, 'Profound thrombocytopenia related to G-CSF', American Journal of Hematology, 82, pp. 229 - 230

Journal articles | 2007

Moore JD; Baichi M; Toledo R; Sitrin M, 2007, 'Pseudomelanosis of jejunum and ileum', Gastrointestinal Endoscopy, 66, pp. 857 - 859,

Journal articles | 2007

Moore JJ; Nivison-Smith I; Goh K; Ma DD; Bradstock KF; Szer J; Durrant S; Schwarer AP; Bardy P; Herrmann RP; Dodds AJ, 2007, 'Equivalent survival for sibling and unrelated donor allogeneic stem cell transplantation for acute myelogenous leukemia', Biology of Blood and Marrow Transplantation, 13, pp. 601 - 607,

Journal articles | 2007

Nivison-Smith I; Bradstock KF; Dodds AJ; Hawkins P; Ma DD; Moore JJ; Simpson JM; Szer J, 2007, 'Hematopoietic stem cell transplantation in Australia and New Zealand, 1992-2004', Biology of Blood and Marrow Transplantation, 13, pp. 905 - 912,

Journal articles | 2006

Al-mashaleh M; Bak H; Moore JJ; Manolios N; Englert H, 2006, 'Resolution of sclerodermatous myocarditis after autologous stem cell transplantation', Annals of the Rheumatic Diseases, 65, pp. 1247 - 1248

Journal articles | 2006

Anandacoomarasamy A; Moore J; McGill N; Manolios N; Englert H, 2006, 'Resolution of skin fibrosis and joint contractures in aggressive diffuse systemic sclerosis using autologous stem cell transplantation', APLAR Journal of Rheumatology, 9, pp. 298 - 301,

Journal articles | 2006

Bai L; Deng Y; Dodds AJ; Milliken ST; Moore JJ; Ma DD, 2006, 'A SYBR green-based real-time PCR method for detection of haemopoietic chimerism in allogenic haemopoietic stem cell transplant recipients', European Journal of Haematology, 77, pp. 425 - 431,

Journal articles | 2006

Bryant A; Moore J, 2006, 'Rituximab and its potential for the treatment of rheumatoid arthritis', Therapeutics and Clinical Risk Management, 2, pp. 207 - 212,

Journal articles | 2006

Carlin S; Moore JJ; Zaunders J; Kelleher AD; Ma DD, 2006, 'T lineage differentiation in vitro of adult Haematopoietic Stem Cells', CYTOMETRY PART A, 69A, pp. 399 - 400,

Journal articles | 2006

Carlin S; Moore JJ; Zaunders J; Kelleher T; Ma DD, 2006, 'Generation in vitro of T lineage cells from human adult haematopoietic stem cells', Clinical Immunology, 119, pp. S160 - S160,

Journal articles | 2006

Dodds AJ; Moore JJ; Goh K; Bradstock KF; Szer J; Nivison-Smith I; Ma DD, 2006, 'A matched pair retrospective comparison of adult unrelated and sibling donor allogeneic stem cell transplantation (SCT) for AML', Biology of Blood and Marrow Transplantation, 12, pp. 27 - 27,

Journal articles | 2006

Pierson RN; Moore J; Merion RM; Azimzadeh AMI, 2006, 'ABO-incompatible lung transplantation', International Congress Series, 1292, pp. 63 - 69,

Journal articles | 2005

Bai L; Deng Y-M; Dodds AJ; Milliken S; Moore J; Ma DDF, 2005, 'A SYBR Green - Based Real Time PCR Method for Detection of Haemopoietic Chimerism in Allogeneic Stem Cell Transplant Recipients.', Blood, 106, pp. 5222 - 5222,

Journal articles | 2005

Bai L; Deng YM; Dodds AJ; Milliken ST; Moore JJ; Ma DD, 2005, 'A SYBR green-based real time PCR method for detection of haemopoietic chimerism in allogeneic stem cell transplant recipients', Blood, 106, pp. 389B - 389B,

Journal articles | 2005

David S; Englert H; Furlong TM; Rainer SP; Moore JJ, 2005, 'Red cell fragmentation preceding a renal crisis in a patient with systemic sclerosis undergoing haematopoietic stem cell transplantation', Bone Marrow Transplantation, 35, pp. 629 - 630,

Journal articles | 2005

Dodds AJ; Ma DD; Milliken ST; Fay K; Cunningham PH; Moore JJ, 2005, 'Cytomegalovirus viraemia after allogeneic transplant: A prospective study of a risk-adapted strategy in a single transplant unit', Blood, 106, pp. 429B - 429B,

Journal articles | 2005

Englert H; Katelaris C; McGill N; Schrieber L; Moore JJ, 2005, '`Grape-sultana` sign represents a favourable response to aggressive treatment of early diffuse systemic scleroderma', Internal Medicine Journal, 35, pp. 436 - 437,

Journal articles | 2005

Gratwohl A; Passweg J; Bocelli-Tyndall C; Fassas A; Van Laar J; Farge D; Andolina M; Arnold RH; Carreras E; Finke J; Kotter I; Kozak T; Lisukov I; Lowenberg B; Marmont A; Moore JJ; Saccardi R; Snowden J; van den Hoogen F; Wulffraat N; Zhou X; Tyndall A, 2005, 'Autologous hematopoietic stem cell transplantation for autoimmune diseases', Bone Marrow Transplantation, 35, pp. 869 - 879

Journal articles | 2005

Johnston AJ; Dodds AJ; Ma DD; Milliken ST; Fay KC; Cunningham PH; Moore JJ, 2005, 'Cytomegalovirus Viraemia after Allogeneic Transplant: A Prospective Study of a Risk-Adapted Strategy in a Single Transplant Unit.', Blood, 106, pp. 5374 - 5374,

Journal articles | 2005

Ma DD; Kovacic JC; Dodds AJ; Tao H; Mcdonald PS; Feneley MP; Muller DW; Fruend J; Milliken ST; Moore JJ; Itescu S; Graham RM, 2005, 'Granulocyte-colony stimulating factor decreases angina and improves exercise capacity in patients with chronic refractory `no option` ischemic heart disease', Blood, 106, pp. 134B - 134B,

Journal articles | 2005

Ma DDF; Kovacic JC; Dodds A; Tao H; McDonald P; Feneley MP; Muller DW; Fruend J; Milliken S; Moore J; Itescu S; Graham RM, 2005, 'Granulocyte-Colony Stimulating Factor Decreases Angina and Improves Exercise Capacity in Patients with Chronic Refractory ‘No Option’ Ischemic Heart Disease.', Blood, 106, pp. 4215 - 4215,

Journal articles | 2005

Ponchel F; Verburg R; Bingham SJ; Brown AK; Moore JJ; Protheroe A; Short K; Lawson C; Morgan AW; Quinn M; Buch M; Field SL; Maltby SL; Masurel A; Douglas SH; Straszynski L; Fearon U; Veale DJ; Patel P; McGonagle D; Snowden J; Markham AF; Ma DD; Van Laar J; Papadaki HA; Emery P; Isaacs JD, 2005, 'Interleukin-7 deficiency in rheumatoid arthritis: consequences for therapy-induced lymphopenia', Arthritis Research and Therapy, 7, pp. 80 - 92

Journal articles | 2004

Bingham S; Moore JJ, 2004, 'Rheumatoid arthritis', Best Practice and Research Clinical Haematology, 17, pp. 263 - 276,

Journal articles | 2004

Moore JJ; Bradstock K; Dodds AJ; Szer J; Smith I; Goh KE; Ma DD, 2004, 'A matched pair retrospective comparison of adult unrelated and sibling donor allogeneic transplantation for AML', Blood, 104, pp. 378B - 378B,

Journal articles | 2004

Moore JJ; Johnston AM; David M; Sam MJ; Keith F; Tony D, 2004, 'Treatment of steroid-refractory acute graft versus host disease with low dose combination monoclonal antibody therapy: A pilot study', Blood, 104, pp. 354A - 354A

Journal articles | 2004

Moore JJ; Ma DD; Dodds T; Milliken ST; Fay K; Concannon A; smith I, 2004, 'Improved disease survival without increased GVHD using low dose cyclosporine and prednisone in allogeneic stem cell transplantation - A case control study', Blood, 104, pp. 371B - 371B,

Journal articles | 2004

Moore JJ; Ma DD; Will R; Cannell P; Handel ML; Milliken ST, 2004, 'A phase II study of Rituximab in rheumatoid arthritis patients with recurrent disease following haematopoietic stem cell transplantation', Bone Marrow Transplantation, 34, pp. 241 - 247,

Journal articles | 2004

Snowden J; Passweg J; Moore JJ; Milliken ST; Cannell P; Van Laar J; Verburg R; Szer J; Taylor KM; Joske D; Rule S; Bingham S; Emery P; Burt R; Lowenthal RM; Durez P; McKendry R; Pavletic S; Espigado I; Jantunen E; Kashyap A; Rabusin M; Brooks PM; Bredeson C; Tyndall A, 2004, 'Autologous hemopoietic stem cell transplantation in severe rheumatoidarthritis: A report from the EBMT and ABMTR', Journal of Rheumatology, 31, pp. 482 - 488

Journal articles | 2004

Zaunders J; Dyer W; Wang B; Munier M; Miranda-Saksena M; Newton R; Moore JJ; MacKay CR; Cooper DA; Saksena NK; Kelleher AD, 2004, 'Identification of circulating antigen-specific CD4+ T lymphocytes with a CCR5+, cytotoxic phenotype in an HIV-1 long-term non-progressor and in CMV infection', Blood, 8, pp. 2765 - 2765

Journal articles | 2004

Zaunders JJ; Dyer WB; Wang B; Munier ML; Miranda-Saksena M; Newton R; Moore J; Mackay CR; Cooper DA; Saksena NK; Kelleher AD, 2004, 'Identification of circulating antigen-specific CD4⁺ T lymphocytes with a CCR5⁺, cytotoxic phenotype in an HIV-1 long-term nonprogressor and in CMV infection', Blood, 103, pp. 2238 - 2247,

Journal articles | 2003

Brooks P; Moore JJ; Tyndall A, 2003, 'Stem cell transplantation in rheumatic diseases', Journal of Rheumatology, 6, pp. 79 - 82

Journal articles | 2003

Moore J; Milliken S; Ma D; Biggs J; Brooks P; Snowden J, 2003, 'CD34-selected versus unmanipulated grafts for severe rheumatoid arthritis: comment on the article by Moore et al - Reply', ARTHRITIS AND RHEUMATISM, 48, pp. 1464 - 1466,

Journal articles | 2003

Moore JJ; Milliken ST; Ma DD; Biggs JC, 2003, 'Letter to the Editor CD34 selected versus unmanipulated grafts for severe rheumatoid arthritis: Reply', Arthritis Care & Research, 48, pp. 1464 - 1466

Journal articles | 2003

Moore JJ; Snowden J; Pavletic S; Barr W; Burt R, 2003, 'Hematopoietic stem cell transplantation for severe rheumatoid arthritis', Bone Marrow Transplantation, 32, pp. 53 - 56,

Journal articles | 2003

Ponchel F; Papadaki H; Bingham S; Verburg R; Moore JJ; Protheroe A; McGonagle D; Snowden J; Van-Laar J; Markham A; Emery P; Isaacs D, 2003, 'Il-7 and therapy-induced lymphopenia in RA', Annals of the Rheumatic Diseases, 62, pp. 164 - 164

Journal articles | 2003

Van Laar JM; Pavletic SZ; Moore J; Milliken S; Ma D; Biggs J; Brooks P; Snowden J, 2003, 'CD34-selected versus unmanipulated grafts for severe rheumatoid arthritis: Comment on the article by Moore et al [4] (multiple letters)', Arthritis and Rheumatism, 48, pp. 1463 - 1464,

Journal articles | 2002

Brooks P; Moore JJ; Tyndall A, 2002, 'A stem cell transplantation and gene therapy in Rheumatoid diseases', Annals of the Rheumatic Diseases

Journal articles | 2002

Moore JJ; Brooks P; Milliken ST; Biggs JC; Ma DD; Handel ML; Will R; Rule S; Joske D; Langlands B; Taylor K; O Callaghan J; Szer J; Wicks I; McColl GJ; Passeullo F; Snowden J, 2002, 'A pilot randomised trial comparing CD34 selected versus unmanipulated haemopoietic stem cell transplanation for severe resistant rheumatoid arthritis', Arthritis Care & Research, 46, pp. 2301 - 2309

Journal articles | 2001

Moore J; Brooks P, 2001, 'Stem cell transplantation for autoimmune diseases', Springer Seminars in Immunopathology, 23, pp. 193 - 213,

Journal articles | 2001

Moore JJ; Brooks P, 2001, 'Haemopoietic stem cell transplantation', Springer Seminars in Immunopathology, pp. 193 - 213

Journal articles | 2001

Moore JJ; Milliken ST; Ma DD; Briggs JW; Brooks P, 2001, 'Peripheral blood stem cell transplantation for rheumatoid arthritis - Australian experience', Journal of Rheumatology, 28, pp. 8 - 12

Journal articles | 2001

Moore JJ; Tyndall A; Brooks P, 2001, 'Stem cells in the aetiopathogenisis and therapy of rheumatic disease.', Best Practice and Research in Clinical Rheumatology, 15, pp. 711 - 726

Journal articles | 2001

Solomon B; Moore JJ; Arthur C; Prince HM, 2001, 'Lack of efficacy of twice-weekly urokinase in the prevention of complications associated with Hickman catheters: A multicentre randomised comparison of urokinase versus heparin', European Journal of Cancer, pp. 2379 - 2384

Journal articles | 2000

Moore J; Aboud M; Ma D, 2000, 'Adult transient lupus anticoagulant patients maintain an acquired activated protein C resistance profile', Thrombosis and Haemostasis, 84, pp. 735 - 736,

Journal articles | 1999

Moore J; Coyle L; Isbister J; Roche J, 1999, 'Bilateral knee osteonecrosis in a patient with thrombotic thrombocytopenic purpura', Australian and New Zealand Journal of Medicine, 29, pp. 88 - 89,

Journal articles | 1998

Moore J; Ma DD; Concannon A, 1998, 'Non-malignant bone marrow necrosis: a report of two cases.', Pathology, 30, pp. 318 - 320,

Journal articles | 1998

Moore J; Ma DDF; Concannon A, 1998, 'Non-malignant bone marrow necrosis: A report of two cases', Pathology, 30, pp. 316 - 318,

Journal articles | 1998

Moore JJ; Isbister JP; Clifton-Bligh P; Eckstein RP, 1998, 'Calcitriol mediated hypercalcaemia in a T cell rich B cell lymphoma [10]', Australian and New Zealand Journal of Medicine, 28, pp. 479 - 480,

Journal articles | 1995

Henry DH; Brooks BJ; Case DC; Fishkin E; Jacobson R; Keller AM; Kugler J; Moore J; Silver RT; Storniolo AM; Abels RI; Gordon DS; Nelson R; Larholt K; Bryant E; Rudnick S, 1995, 'Recombinant human erythropoietin therapy for anemic cancer patients receiving cisplatin chemotherapy.', The cancer journal from Scientific American, 1, pp. 252 - 260
Conference Abstracts | 2022

Chadwick V; Kim M; Mills G; Tang C; Anazodo A; Dear R; Rodgers R; Lavee O; Milliken S; McCaughan G; Moore J; Hamad N; Hurwitz J, 2022, 'A minority of women of child bearing potential are tested for pregnancy before chemoimmunotherapy: An Australian Cancer Centre Experience', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 18, pp. 209 - 210,

Conference Abstracts | 2022

Chadwick V; Kim M; Mills G; Tang C; Anazodo A; Dear R; Rodgers R; Lavee O; Milliken S; McCaughan G; Moore J; Hamad N; Hurwitz J, 2022, 'Rates of contraceptive uptake and documentation of discussion with anticancer therapy: Women deserve gender specific care', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 18, pp. 209 - 209,

Conference Abstracts | 2022

Chadwick V; Kim M; Mills G; Tang C; Anazodo A; Dear R; Rodgers R; Lavee O; Milliken S; McCaughan G; Moore J; Hamad N; Hurwitz J, 2022, 'Rates of fertility discussions and counselling before, during and after anticancer treatments: Women deserve gender specific care', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 18, pp. 175 - 175,

Conference Abstracts | 2022

Chadwick V; Kim M; Mills G; Tang C; Anazodo A; Dear R; Rodgers R; Lavee O; Milliken S; Moore J; McCaughan G; Hamad N; Hurwitz J, 2022, 'Rate of menstruation history taking and counselling before, during and after anticancer treatments', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 18, pp. 174 - 175,

Conference Abstracts | 2022

Chadwick V; Kim M; Mills G; Tang C; Anazodo A; Dear R; Rogers R; Lavee O; Milliken S; McCaughan G; Moore J; Hamad N; Hurwitz J, 2022, 'Rates of sexual history taking and sexual dysfunction counselling with cancer care', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 18, pp. 175 - 176,

Conference Abstracts | 2022

Hu H; Carr A; Deenick E; Phan TT; Kelleher A; Tong W; Moore J; Evans L; Toong C; Murad A; Kane A, 2022, 'PATIENT PERCEPTIONS OF HEALTH-RELATED QUALITY OF LIFE IN AN AUSTRALIAN ADULT PRIMARY IMMUNODEFICIENCY COHORT', in INTERNAL MEDICINE JOURNAL, WILEY, Vol. 52, pp. 27 - 27,

Conference Papers | 2022

Massey J; Jackson K; Singh M; Hughes B; Ford C; Khoo M; Hendrawan K; Zaunders J; Charmeteau-De Muylder B; Cheynier R; Luciani F; Ma D; Moore J; Sutton I, 2022, 'Haematopoietic stem cell transplantation for Multiple Sclerosis results in deletion of auto-reactive public CD4+T-cell clones', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, pp. 20 - 20,

Conference Papers | 2022

Massey J; Jackson K; Singh M; Hughes B; Ford C; Khoo M; Hendrawan K; Zaunders J; Charmeteau-De Muylder B; Cheynier R; Luciani F; Ma D; Moore J; Sutton I, 2022, 'Haematopoietic stem cell transplantation for Multiple Sclerosis results in deletion of auto-reactive public CD4+T-cell clones', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, AUSTRALIA, Hobart, pp. 20 - 20, presented at MS Australia Progress in MS Research Scientific Conference, AUSTRALIA, Hobart, 04 April 2022 - 05 April 2022,

Conference Abstracts | 2022

Moore J; Penglase R; Englert H; Milliken S; Withers B; Karki N; Perram J; Tao H; Jabbour A; Kotylar E; Ma D, 2022, 'Low dose cyclophosphamide conditioning is safe in systemic sclerosis patients ineligible for standard dose regimens - an interim analysis of the prospective assure trial', in BONE MARROW TRANSPLANTATION, SPRINGERNATURE, CZECH REPUBLIC, Vol. 57, pp. 25 - 25, presented at 48th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), CZECH REPUBLIC, 19 March 2022 - 23 March 2022,

Conference Abstracts | 2022

Penglase R; Brenu E; Englert H; Milliken S; Withers B; Karki N; Perram J; Tao H; Girgis L; Jabbour A; Kotlyar E; Ma D; Moore J, 2022, 'NT-proBNP measurements during cyclophosphamide conditioning in patients undergoing autologous haemopoietic stem cell transplantation for systemic sclerosis suggest increased cardiac strain', in BONE MARROW TRANSPLANTATION, SPRINGERNATURE, CZECH REPUBLIC, Vol. 57, pp. 128 - 128, presented at 48th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), CZECH REPUBLIC, 19 March 2022 - 23 March 2022,

Conference Abstracts | 2022

Penglase R; Girgis L; Englert H; Jabbour A; Kotlyar E; Karki N; Withers B; Milliken S; Ma D; Moore J, 2022, 'AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANTATION FOR SEVERE SYSTEMIC SCLEROSIS USING STANDARD DOSE CYCLOPHOSPHAMIDE CONDITIONING - A SINGLE CENTRE EXPERIENCE', in INTERNAL MEDICINE JOURNAL, WILEY, Vol. 52, pp. 10 - 10,

Conference Abstracts | 2022

Perram J; Hamad N; Moore J, 2022, 'Low rates of testing and high prevalence of vitamin d deficiency before and after transplantation at an australian transplant centre', in BONE MARROW TRANSPLANTATION, SPRINGERNATURE, CZECH REPUBLIC, Vol. 57, pp. 353 - 354, presented at 48th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), CZECH REPUBLIC, 19 March 2022 - 23 March 2022,

Conference Abstracts | 2021

Massey J; Jackson K; Singh M; Hughes B; Ford C; Zaunders J; Charmeteau-De-Muylder B; Cheynier R; Luciani F; Ma D; Moore J; Sutton I, 2021, 'Haematopoietic stem cell transplantation for multiple sclerosis results in deletion of auto-reactive public CD4+T-cell clones', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, Vol. 27, pp. 349 - 349,

Conference Papers | 2021

Penglase R; Visweswaran M; Zaunders J; Girgis L; Ma D; Moore J, 2021, 'Autologous Haematopoietic Stem Cell Transplantation for Systemic Sclerosis Results in Sustained Changes in Immunoregulatory T and NK Cells', in ARTHRITIS & RHEUMATOLOGY, WILEY, pp. 1113 - 1114,

Conference Abstracts | 2020

McCaughan GJ; Verma A; Ling S; Lavee O; Moore J; Bryant A, 2020, 'Weekly Cyclophosphamide, Subcutaneous Bortezomib and Dexamethathasone (CyBorD) for Initial Treatment of Transplant Eligible Patients with Multiple Myeloma: Experience of Two Transplant Centres', in Blood, American Society of Hematology, Vol. 136, pp. 42 - 43,

Conference Abstracts | 2020

Saccardi R; Badoglio M; Burman J; Helbig G; Innocenti C; Kazmi M; Mancardi GL; Moore J; Muraro P; Sharrack B; Smilowski M; Sormani MP; Snowden JA, 2020, 'Beam vs Cyclophosphamide-Based Conditioning Regimen in Aggressive Multiple Sclerosis: A Retrospective Analysis of European Blood and Marrow Transplantation Society', in BONE MARROW TRANSPLANTATION, SPRINGERNATURE, Vol. 55, pp. 37 - 38,

Conference Abstracts | 2020

Sharrack B; Saccardi R; Alexander T; Manuela B; Burman J; Farge D; Greco R; Jessop H; Kazmi M; Kirgizov K; Labopin M; Mancardi G; Martin R; Moore J; Muraro P; Rovira M; Sormani MP; Snowden J, 2020, 'Autologous haematopoietic stem cell transplantation in multiple sclerosis and other immune-mediated neurological diseases: guidelines and recommendations of the European Society for Blood and Marrow Transplantation and the Joint Accreditation Committee of the International Society for Cellular Therapy', in NEUROLOGY, LIPPINCOTT WILLIAMS & WILKINS, CANADA, Toronto, Vol. 94, presented at Annual Meeting of the American-Academy-of-Neurology, CANADA, Toronto, 25 April 2020 - 01 May 2020,

Conference Papers | 2019

Cashman H; Hamad N; Moore J; Milliken S; Lavee O; Withers B; Mayson E; Kliman D; Kesby J; Bell J; Vachalec S, 2019, 'An Electronic Health Record Facilitates a Safer and More Efficient Rural Outreach Haematology/Oncology Service', in BLOOD, AMER SOC HEMATOLOGY, FL, Orlando, presented at 61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), FL, Orlando, 07 December 2019 - 10 December 2019,

Conference Papers | 2019

Fleming S; Venn N; Reynolds J; Nguyen U; Kwan J; Moore J; Yeung DT; Leahy MF; Greenwood M; Verner E; Bajel A; Berkahn L; Wei AH; Sutton R, 2019, 'Preliminary Minimal Residual Disease Analysis of the Australasian Leukaemia & Lymphoma Group (ALLG) ALL8 Study of Front-Line Blinatumomab with Chemotherapy in Adults with Ph Negative B-Cell Acute Lymphoblastic Leukaemia', in BLOOD, AMER SOC HEMATOLOGY, FL, Orlando, presented at 61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), FL, Orlando, 07 December 2019 - 10 December 2019,

Conference Papers | 2019

Hardefeldt P; Moore J; Milliken S; Fay K; Orly L; Mayson E; Withers B; Hamad N, 2019, 'Dose Adjusted R-EPOCH Does Not Improve Outcomes in High Grade B Cell Lymphoma with Double Expressor Status or Gain of MYC/BCL2', in BLOOD, AMER SOC HEMATOLOGY, FL, Orlando, presented at 61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), FL, Orlando, 07 December 2019 - 10 December 2019,

Conference Abstracts | 2019

Hendrawan K; Ford C; Khoo M; Zaunders J; Molloy T; Ma D; Moore J, 2019, 'CD39+T regulatory cell reconstitution in MS patients with different CD39 gene polymorphisms undergoing autologous HSCT: A Preliminary Study', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, AUSTRALIA, Melbourne, Vol. 26, pp. NP18 - NP18, presented at Conference of MS-Research-Australia, AUSTRALIA, Melbourne, 31 October 2019 - 01 November 2019,

Conference Papers | 2019

Massey J; Ford C; Khoo M; Cheynier R; Charmantu B; Zaunders J; Hendrawan K; Sutton I; Withers B; Milliken S; Ma D; Moore J, 2019, 'Immune reconstitution following autologous haematopoietic stem cell transplantation for multiple sclerosis is driven by sustained thymic reactivation', in BONE MARROW TRANSPLANTATION, NATURE PUBLISHING GROUP, GERMANY, Frankfurt, pp. 32 - 33, presented at 45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), GERMANY, Frankfurt, 24 March 2019 - 27 March 2019,

Conference Papers | 2018

Ford CD; Khoo M; Zaunders J; Massey J; Hendrawan K; Sutton I; Ma DDF; Moore JJ, 2018, 'Analysis of Immune Reconstitution by Multicolour Flow Cytometry in Multiple Sclerosis and Non-Autoimmune Patients Following Autologous Haematopoietic Stem Cell Transplantation', in BONE MARROW TRANSPLANTATION, NATURE PUBLISHING GROUP, PORTUGAL, Lisbon, pp. 203 - 203, presented at 44th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), PORTUGAL, Lisbon, 18 March 2018 - 21 March 2018,

Conference Abstracts | 2017

Ford C; Khoo M; Zaunders J; Hendrawan K; Massey J; Sutton I; Milliken S; Ma D; Moore JJ, 2017, 'Identification of the immune phenotypes associated with haematopoietic stem cell transplantation for Multiple Sclerosis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, AUSTRALIA, MS Res Australia, Sydney, Vol. 23, pp. NP23 - NP23, presented at Progress in MS Research Conference, AUSTRALIA, MS Res Australia, Sydney, 11 October 2017 - 13 October 2017,

Conference Papers | 2016

Dyer G; Gilroy N; Brice L; Greenwood M; Kabir M; Larsen SR; Hertzberg M; Brown L; Hogg M; Huang G; Moore J; Tan J; Kwan J; Ward C; Kerridge I, 2016, 'The experience of survival following Blood and Marrow Transplant in NSW, Australia', in BONE MARROW TRANSPLANTATION, NATURE PUBLISHING GROUP, SPAIN, Valencia, pp. S224 - S225, presented at 42nd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, SPAIN, Valencia, 03 April 2016 - 06 April 2016,

Other | 2016

Dyer G; Gilroy N; Brown L; Hogg M; Brice L; Kabir M; Greenwood M; Larsen SR; Moore J; Hertzberg M; Kwan J; Huang G; Tan J; Ward C; Kerridge I, 2016, Erratum: Erratum to: “What They Want: Inclusion of Blood and Marrow Transplantation Survivor Preference in the Development of Models of Care for Long-Term Health in Sydney, Australia” (Biol Blood Marrow Transplant (2016) 22 (731–743)), ,

Conference Papers | 2016

Kenneth B; Link E; Di Iulio J; Szer J; Marlton P; Wei A; Enno A; Schwarer AP; Lewis ID; D'Rozario J; Coyle L; Cull G; Campbell P; Leahy MF; Hahn UH; Cannell P; Tiley C; Lowenthal RM; Moore J; Cartwright K; Cunningham I; Taper J; Grigg A; Roberts AW; Benson WJ; Hertzberg MS; Deveridge SF; Rowlings PA; Mills AK; Gill DS; Bardy PG; Campbell L; Seymour JF, 2016, 'Increased Idarubicin Dosage during Consolidation Therapy for Adult Acute Myeloid Leukemia Improves Leukemia-Free Survival', in BLOOD, AMER SOC HEMATOLOGY, CA, San Diego, presented at 58th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), CA, San Diego, 03 December 2016 - 06 December 2016,

Conference Abstracts | 2016

Lindsay J; Kabir M; Gilroy N; Dyer G; Brice L; Greenwood M; Moore J; Hertzberg M; Larsen S; Kwan J; Brown L; Hogg M; Huang G; Tan J; Gifford G; Kerridge I, 2016, 'Complementary and Alternative Medicine Therapy (CAM) Use by Allogeneic BMT Survivorship Patients', in BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, ELSEVIER SCIENCE INC, Honolulu, HI, Vol. 22, pp. S476 - S476, presented at BMT Tandem Meetings, Honolulu, HI, 18 February 2016 - 22 February 2016,

Reports | 2015

Bhattacharyya A; Sahhar J; Milliken S; Ma D; Englert H; Tymms K; Danta M; Moore J, 2015, Autologous hematopoietic stem cell transplant for systemic sclerosis improves anemia from gastric antral vascular ectasia,

Conference Papers | 2014

Kumarasinghe G; Lavee O; Nivison-Smith I; Parker A; Malouf M; Keogh A; Milliken S; Dodds A; Plit M; Hayward C; Ma D; Fay K; Joseph J; Kotlyar E; Havryk A; Jabbour A; Glanville A; Macdonald P; Moore J, 2014, 'Defining Prognostic Markers in Heart and Lung Transplant Recipients with PTLD', in JOURNAL OF HEART AND LUNG TRANSPLANTATION, ELSEVIER SCIENCE INC, CA, San Diego, pp. S84 - S84, presented at 34th Annual Meeting and Scientific Sessions of the International-Society-for-Heart-and-Lung-Transplantation, CA, San Diego, 10 April 2014 - 13 April 2014,

Conference Papers | 2014

Lim ABM; Curley C; Fong CY; Bilmon I; Beligaswatte A; Purtill D; Getta B; Johnston AM; Armytage T; Collins M; Mason K; Fielding K; Greenwood M; Gibson J; Hertzberg M; Wright M; Lewis I; Moore J; Curtis D; Szer J; Kennedy G; Ritchie DS, 2014, 'The Australian Experience with Relapsed Acute Myeloid Leukaemia Post Allogeneic Haematopoietic Stem Cell Transplantation Yields a Simple Prognostic Index for Survival after Relapse', in BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, ELSEVIER SCIENCE INC, TX, Grapevine, pp. S38 - S39, presented at BMT Tandem Meetings, TX, Grapevine, 26 February 2014 - 02 March 2014,

Conference Papers | 2014

Oliveira MC; Labopin M; Henes J; Moore J; Del Papa N; Stanciu R; Sakellari I; Schroers R; Scherer HU; Kyrcz-Krzemien S; Daikeler T; Alexander T; Finke J; Badoglio M; Snowden JA; Farge D, 2014, 'Does Ex Vivo CD34+Cell Selection Change the Outcome of Systemic Sclerosis Patients Treated with Autologous Hematopoietic Stem Cell Transplantation (AHSCT), an Adwp EBMT Study?', in BLOOD, AMER SOC HEMATOLOGY, CA, San Francisco, presented at 56th Annual Meeting of the American-Society-of-Hematology, CA, San Francisco, 06 December 2014 - 09 December 2014,

Conference Papers | 2013

Ibrahim K; Moore J; Horne A, 2013, 'Successful Stem Cell Mobilisation with Plerixafor in a Patient with Multiple Myeloma and Dialysis-Dependant Renal Failure', in BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, ELSEVIER SCIENCE INC, UT, Salt Lake City, pp. S184 - S184, presented at BMT Tandem Meetings, UT, Salt Lake City, 13 February 2013 - 17 February 2013,

Conference Papers | 2013

Khoo M; Carlin S; Lutherborrow M; Ma D; Moore J, 2013, 'GENE ARRAY ANALYSIS OF HUMAN HEMATOPOIETIC STEM CELLS REVEALS ASSOCIATION BETWEEN AGE, ALTERED SIGNALING AND LOSS OF LYMPHOCYTE POTENTIAL', in EXPERIMENTAL HEMATOLOGY, ELSEVIER SCIENCE INC, AUSTRIA, Vienna, pp. S33 - S33, presented at 42nd Annual Scientific Meeting of the International-Society-for-Experimental-Hematology-and-Stem-Cells (ISEH), AUSTRIA, Vienna, 22 August 2013 - 25 August 2013,

Conference Papers | 2013

Kumarasinghe G; Lavee O; Parker A; Keogh A; Hayward C; Kotlyar E; Jabbour A; Havryk A; Malouf M; Plit M; Glanville A; Macdonald P; Moore J, 2013, 'Risk Factors and Response to Therapy in Heart and Lung Transplant Recipients with Post-Transplant Lymphoproliferative Disease', in JOURNAL OF HEART AND LUNG TRANSPLANTATION, ELSEVIER SCIENCE INC, CANADA, Montreal, pp. S254 - S254, presented at 33rd Annual Meeting and Scientific Sessions of the International-Society-for-Heart-and-Lung-Transplantation, CANADA, Montreal, 24 April 2013 - 27 April 2013,

Conference Abstracts | 2011

Bryant AJ; Pillai E; Kennedy G; Kalff A; Ritchie D; George B; Hertzberg M; Patil SS; Spencer A; Fay K; Cannell P; Berkahn L; Doocey R; Spearling R; Nivison-Smith I; Moore J, 2011, 'A Retrospective Analysis of 344 Fludarabine Melphalan RIC Allogeneic Stem Cell Transplants for Myeloid and Lymphoid Malignancies In Australia and New Zealand 1998–2008,', in Blood, American Society of Hematology, Vol. 118, pp. 4143 - 4143,

Conference Abstracts | 2007

Bryant A; Moore JJ; Dodds AJ; Milliken ST; Fay K; Ma DD, 2007, 'Pneumonitis and renal toxicity with sirolimus based GVHD prophylaxis for RIC allogeneic', in Haematologica - the Hematology Journal, Ferrata Storti Foundation, Vol. 92, pp. 516 - 516

Conference Papers | 2007

Kovacic JC; Macdonald P; Feneley MP; Muller DW; Ma D; Tao H; Freund J; Milliken S; Dodds A; Moore J; Itescu S; Graham RM, 2007, 'The use of granulocyte-colony stimulating factor in angina patients to stimulate neovascularization: the GAIN I study', in CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, FL, Orlando, pp. 591 - 592, presented at 80th Annual Scientific Session of the American-Heart-Association, FL, Orlando, 04 November 2007 - 07 November 2007,

Conference Papers | 2007

Kovacic JC; Macdonald PS; Feneley MP; Muller DW; Ma DD; Tao H; Freund J; Milliken ST; Dodds AJ; Moore JJ; Itescu S; Graham RM, 2007, 'The use of granulocyte-colony stimulating factor in angina patients to stimulate neovascularization: the GAIN I study', in Circulation, Lippincott Williams & Wilkins, Philadelphia, PA, USA, pp. 2669 - 2670, presented at 80th Annual Scientific Session of the American-Heart-Association, Orlando, Florida, USA, 04 November 2007 - 07 November 2007

Preprints |

Walker I; Panzarella T; Couban S; Couture F; Devins G; Elemary M; Gallagher G; Kerr H; Kuruvilla J; Lee S; Moore J; Nevill T; Popradi G; Roy J; Schultz KR; Szwajcer D; Toze C; Foley R, Anti-Thymocyte Globulin for Patients Undergoing Hematopoietic Cell Transplantation from Unrelated Donors: A Randomized, Controlled, Open-Label, Phase 3, Multicentre Trial from Cell Therapy Transplant Canada, ,

My Research Supervision

PhD Supervisor – Kevin Hendrawan, Faculty of Medicine, UNSW, 2017-present. “Determining the mechanisms of tolerance after autologous stem cell transplantation for Multiple Sclerosis – the role of CD39+ T regulatory cells”

PhD Supervisor – Jennifer Massey, Faculty of Medicine, UNSW, 2017- present. “Immuno-biological, Radiological and Clinical correlates in Haematopoietic Stem Cell Transplantation for Multiple Sclerosis”

51�Թ�app

Follow

Dr John Moore